These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 21763370)
1. Targeted TFO delivery to hepatic stellate cells. Yang N; Singh S; Mahato RI J Control Release; 2011 Oct; 155(2):326-30. PubMed ID: 21763370 [TBL] [Abstract][Full Text] [Related]
2. HPMA polymer-based site-specific delivery of oligonucleotides to hepatic stellate cells. Yang N; Ye Z; Li F; Mahato RI Bioconjug Chem; 2009 Feb; 20(2):213-21. PubMed ID: 19133717 [TBL] [Abstract][Full Text] [Related]
3. Receptor-mediated hepatic uptake of M6P-BSA-conjugated triplex-forming oligonucleotides in rats. Ye Z; Cheng K; Guntaka RV; Mahato RI Bioconjug Chem; 2006; 17(3):823-30. PubMed ID: 16704223 [TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of a triplex-forming oligonucleotide to hepatic stellate cells. Ye Z; Cheng K; Guntaka RV; Mahato RI Biochemistry; 2005 Mar; 44(11):4466-76. PubMed ID: 15766277 [TBL] [Abstract][Full Text] [Related]
5. Biodistribution and hepatic uptake of triplex-forming oligonucleotides against type alpha1(I) collagen gene promoter in normal and fibrotic rats. Cheng K; Ye Z; Guntaka RV; Mahato RI Mol Pharm; 2005; 2(3):206-17. PubMed ID: 15934781 [TBL] [Abstract][Full Text] [Related]
6. Enhanced hepatic uptake and bioactivity of type alpha1(I) collagen gene promoter-specific triplex-forming oligonucleotides after conjugation with cholesterol. Cheng K; Ye Z; Guntaka RV; Mahato RI J Pharmacol Exp Ther; 2006 May; 317(2):797-805. PubMed ID: 16452392 [TBL] [Abstract][Full Text] [Related]
7. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells. Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133 [TBL] [Abstract][Full Text] [Related]
8. Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities. Brunet E; Corgnali M; Perrouault L; Roig V; Asseline U; Sørensen MD; Babu BR; Wengel J; Giovannangeli C Nucleic Acids Res; 2005; 33(13):4223-34. PubMed ID: 16049028 [TBL] [Abstract][Full Text] [Related]
9. DNA damage produced by 125I-triplex-forming oligonucleotides as a measure of their successful delivery into cell nuclei. Panyutin IV; Sedelnikova OA; Bonner WM; Panyutin IG; Neumann RD Ann N Y Acad Sci; 2005 Nov; 1058():140-50. PubMed ID: 16394133 [TBL] [Abstract][Full Text] [Related]
10. Mannose 6-phosphate-modified bovine serum albumin nanoparticles for controlled and targeted delivery of sodium ferulate for treatment of hepatic fibrosis. Li FQ; Su H; Chen X; Qin XJ; Liu JY; Zhu QG; Hu JH J Pharm Pharmacol; 2009 Sep; 61(9):1155-61. PubMed ID: 19703364 [TBL] [Abstract][Full Text] [Related]
11. Transplatin-conjugated triplex-forming oligonucleotides form adducts with both strands of DNA. Campbell MA; Miller PS Bioconjug Chem; 2009 Dec; 20(12):2222-30. PubMed ID: 19950917 [TBL] [Abstract][Full Text] [Related]